Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TERT promoter mutations and long-term survival in patients with thyroid cancer.

Endocrine-related cancer - 1 Oct 2016

Kim Tae Hyuk, Kim Young-Eun, Ahn Soomin, Kim Ji-Youn, Ki Chang-Seok, Oh Young Lyun, Kim Kyunga, Yun Jae Won, Park Woong-Yang, Choe Jun-Ho, Kim Jung-Han, Kim Jee Soo, Kim Sun Wook, Chung Jae Hoon

Abstract excerpt

TERT promoter mutations are emerging prognostic biomarkers in multiple cancers and are found in highly aggressive thyroid cancer. Our aim is to investigate the prognostic value of these mutations for the outcome of thyroid cancer-related mortality in a large cohort of thyroid cancer patients. This was a retrospective study of 409 patients (393 with differentiated thyroid cancer) with a median age of 44 years...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Promoter Regions, Genetic

Share to Survival Analysis

Share to Telomerase

Share to Thyroid Neoplasms

Share to Young Adult

Source

Identifiers

PMID: 27528624
DOI: 10.1530/ERC-16-0219

Genes

TERT
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TERT promoter mutations and long-term survival in patients with thyroid cancer.PMID 27528624Read ↗

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.Semantic proximity Read ↗

TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis.Semantic proximity Read ↗

BRAF and TERT promoter mutations: clinical application in thyroid cancer.Semantic proximity Read ↗

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.Semantic proximity Read ↗

Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis.Semantic proximity Read ↗

Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

TERT promoter mutations in thyroid cancer.Semantic proximity Read ↗

How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?Semantic proximity Read ↗

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas.Semantic proximity Read ↗

Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid CancerSemantic proximity Read ↗

Value of TERT promoter mutations for early outcomes in papillary thyroid cancer.Semantic proximity Read ↗

TERT promoter mutations in thyroid cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.